UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention

Alimentary pharmacology & therapeutics, 2013-10, Vol.38 (8), p.967-976

2013

Volltextzugriff (PDF)

Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982–2002

Alimentary pharmacology & therapeutics, 2006-07, Vol.24 (1), p.65-79

2006

Volltextzugriff (PDF)

Systematic review: do we need a new gastro-oesophageal reflux disease questionnaire?

Alimentary pharmacology & therapeutics, 2004-03, Vol.19 (5), p.463-479

2004

Volltextzugriff (PDF)

Tegaserod, a 5‐HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

Alimentary pharmacology & therapeutics, 2001-10, Vol.15 (10), p.1655-1666

2001

Volltextzugriff (PDF)

Breathomics-exhaled volatile organic compound analysis to detect hepatic encephalopathy: a pilot study

Journal of breath research, 2016-02, Vol.10 (1), p.016012-016012

2016

Volltextzugriff (PDF)

Development and application of a new electronic nose instrument for the detection of colorectal cancer

Biosensors & bioelectronics, 2015-05, Vol.67, p.733-738

2015

Volltextzugriff (PDF)

The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies

Gastroenterology (New York, N.Y. 1943), 1999-02, Vol.116 (2), p.248-253

1999

Volltextzugriff (PDF)

A double‐blind, randomized, placebo‐controlled dose‐ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome

Alimentary pharmacology & therapeutics, 2000-01, Vol.14 (1), p.23-34

2000

Volltextzugriff (PDF)

Primary gastroduodenal prophylaxis with omeprazole for non‐steroidal anti‐inflammatory drug users

Alimentary pharmacology & therapeutics, 1998-02, Vol.12 (2), p.135-140

1998

Volltextzugriff (PDF)

One week triple therapy for Helicobacter pylori: a multicentre comparative study

Gut, 1997-12, Vol.41 (6), p.735-739

1997

Volltextzugriff (PDF)

International validation of ReQuest in patients with endoscopy‐negative gastro‐oesophageal reflux disease

Alimentary pharmacology & therapeutics, 2004-10, Vol.20 (8), p.891-898

2004

Volltextzugriff (PDF)

The scars of time: the disappearance of peptic ulcer-related pyloric stenosis through the 20th century

The Journal of the Royal College of Physicians of Edinburgh, 2014, Vol.44 (3), p.201-208

2014

Volltextzugriff (PDF)

A clinical trial comparing pantoprazole and esomeprazole to explore the concept of achieving ‘complete remission’ in gastro‐oesophageal reflux disease

Alimentary pharmacology & therapeutics, 2007-06, Vol.25 (12), p.1461-1469

2007

Volltextzugriff (PDF)

Intestinal secretory and absorptive function in Trichinella spiralis mouse model of postinfective gut dysfunction: role of bile acids

Gut, 2008-01, Vol.57 (1), p.41-48

2008

Volltextzugriff (PDF)

Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine

BMJ, 1999-02, Vol.318 (7182), p.502-507

International edition, 1999

Volltextzugriff (PDF)

A randomized, double‐blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro‐oesophageal reflux disease over 5 years

Alimentary pharmacology & therapeutics, 2003-02, Vol.17 (3), p.343-351

2003

Volltextzugriff (PDF)

Emergency admissions for upper gastrointestinal disease and their relation to NSAID use

Alimentary pharmacology & therapeutics, 1997-04, Vol.11 (2), p.283-291

1997

Volltextzugriff (PDF)

The role of proton pump inhibitors in the treatment of gastro‐oesophageal reflux disease

Alimentary pharmacology & therapeutics, 1995-04, Vol.9 (s1), p.15-25

BARDHAN, K. D.

1995

Volltextzugriff (PDF)

Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia

Gut, 1997-11, Vol.41 (5), p.664-668

1997

Volltextzugriff (PDF)

Dietary Phosphilipids and Sterols Protective against Peptic Ulceration

Phytotherapy research, 2013-09, Vol.27 (9), p.1265-1269

2013

Volltextzugriff (PDF)

Comparable clinical efficacy and tolerability of 20 mg pantoprazole and 20 mg omeprazole in patients with grade I reflux oesophagitis

Alimentary pharmacology & therapeutics, 2001-10, Vol.15 (10), p.1585-1591

2001

Volltextzugriff (PDF)

The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study

Alimentary pharmacology & therapeutics, 2004-07, Vol.20 (2), p.213-222

2004

Volltextzugriff (PDF)

Admission rates for peptic ulcer in the Trent Region, UK, 1972–2000: Changing pattern, a changing disease?

Digestive and liver disease, 2004-09, Vol.36 (9), p.577-588

2004

Volltextzugriff (PDF)

Reflux rising! An essay on witnessing a disease in evolution

Digestive and liver disease, 2006-03, Vol.38 (3), p.163-168

2006

Volltextzugriff (PDF)

Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuest

Digestion, 2004-01, Vol.69 (4), p.229-237

2004

Volltextzugriff (PDF)

1 – 25 von 440

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(398)
Mit Volltextzugriff
(349)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Gut
(56)
Alimentary Pharmacology & Therapeutics
(36)
The Lancet
(32)
Bmj
(21)
Bmj. British Medical Journal
(20)
British Medical Journal
(17)
Gastroenterology
(16)
The American Journal Of Gastroenterology
(14)
Digestion
(12)
Digestive Diseases And Sciences
(10)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention

Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982–2002

Systematic review: do we need a new gastro-oesophageal reflux disease questionnaire?

Tegaserod, a 5‐HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

Breathomics-exhaled volatile organic compound analysis to detect hepatic encephalopathy: a pilot study

Development and application of a new electronic nose instrument for the detection of colorectal cancer

The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies

A double‐blind, randomized, placebo‐controlled dose‐ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome

Primary gastroduodenal prophylaxis with omeprazole for non‐steroidal anti‐inflammatory drug users

One week triple therapy for Helicobacter pylori: a multicentre comparative study

International validation of ReQuest in patients with endoscopy‐negative gastro‐oesophageal reflux disease

The scars of time: the disappearance of peptic ulcer-related pyloric stenosis through the 20th century

A clinical trial comparing pantoprazole and esomeprazole to explore the concept of achieving ‘complete remission’ in gastro‐oesophageal reflux disease

Intestinal secretory and absorptive function in Trichinella spiralis mouse model of postinfective gut dysfunction: role of bile acids

Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine

A randomized, double‐blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro‐oesophageal reflux disease over 5 years

Emergency admissions for upper gastrointestinal disease and their relation to NSAID use

The role of proton pump inhibitors in the treatment of gastro‐oesophageal reflux disease

Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia

Dietary Phosphilipids and Sterols Protective against Peptic Ulceration

Comparable clinical efficacy and tolerability of 20 mg pantoprazole and 20 mg omeprazole in patients with grade I reflux oesophagitis

The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study

Admission rates for peptic ulcer in the Trent Region, UK, 1972–2000: Changing pattern, a changing disease?

Reflux rising! An essay on witnessing a disease in evolution

Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuest

Suchergebnisse filtern